CSF1R and neoplasm: One particular mechanism of therapeutic interference was revealed when paclitaxel treatment of PyMT mice was shown to increase tumor cell secretion of CSF-1 and IL-34 and addition of a CSF-1R inhibitor to the treatment regime reduced tumor growth and rates of pulmonary metastasis (116).